Nicolas Véziris

6.8k citations

139 papers · 3.5k indexed · h-index 32

Impact in

Infectious Diseases top 0.5%
- Tuberculosis Research and Epidemiology
Microbiology top 1%

Papers in ⓘ

Infectious Diseases 121
- Tuberculosis Research and Epidemiology 115
Epidemiology 109
- Mycobacterium research and diagnosis 87
- Pneumocystis jirovecii pneumonia detection and treatment 18

Co-authors: Vincent Jarlier (49 shared papers)Florence Brossier (26 shared papers)C. Truffot-Pernot (15 shared papers)Alexandra Aubry (43 shared papers)Wladimir Sougakoff (31 shared papers)Emmanuelle Cambau (13 shared papers)Nacer Lounis (9 shared papers)Aurélie Chauffour (17 shared papers)
Journals: Antimicrobial Agents and Chemotherapy (18 papers)Journal of Clinical Microbiology (9 papers)Journal of Antimicrobial Chemotherapy (7 papers)Emerging infectious diseases (6 papers)PLoS neglected tropical diseases (6 papers)
Partner nations: France Morocco United States

In The Last Decade

Nicolas Véziris

130 papers receiving 3.4k citations

Peers

Countries citing papers authored by Nicolas Véziris

Since Specialization

Citations

This map shows the geographic impact of Nicolas Véziris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Véziris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Véziris more than expected).

Fields of papers citing papers by Nicolas Véziris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Véziris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Véziris. The network helps show where Nicolas Véziris may publish in the future.

Co-authors

The 25 scholars most cited alongside Nicolas Véziris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nicolas Véziris Line = papers co-authored together Nicolas Véziris links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Peptidoglycan of Stationary-Phase Mycobacterium tuberculosis Predominantly Contains Cross-Links Generated by l,d -Transpeptidation Journal of Bacteriology ·Marie Lavollay, Michel Arthur, Martine Fourgeaud, Lionel Dubost, Arul Marie, Nicolas Véziris, Didier Blanot, Laurent Gutmann, Jean‐Luc Mainardi	2008	272
2	Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm (41) and rrl Sequencing Antimicrobial Agents and Chemotherapy ·Sylvaine Bastian, Nicolas Véziris, Anne‐Laure Roux, Florence Brossier, Jean‐Louis Gaillard, Vincent Jarlier, Emmanuelle Cambau	2010	269
3	Novel Gyrase Mutations in Quinolone-Resistant and -Hypersusceptible Clinical Isolates of Mycobacterium tuberculosis : Functional Analysis of Mutant Enzymes Antimicrobial Agents and Chemotherapy ·Alexandra Aubry, Nicolas Véziris, Emmanuelle Cambau, C. Truffot-Pernot, Vincent Jarlier, L. Mark Fisher	2005	155
4	Detection by GenoType MTBDR sl Test of Complex Mechanisms of Resistance to Second-Line Drugs and Ethambutol in Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates Journal of Clinical Microbiology ·Florence Brossier, Nicolas Véziris, Alexandra Aubry, Vincent Jarlier, Wladimir Sougakoff	2010	151
5	Synergistic Activity of R207910 Combined with Pyrazinamide against Murine Tuberculosis Antimicrobial Agents and Chemotherapy ·Michella Ibrahim, Koen Andries, Nacer Lounis, Aurélie Chauffour, C. Truffot-Pernot, Vincent Jarlier, Nicolas Véziris	2006	130
6	Rapid Identification of Mycobacterial Whole Cells in Solid and Liquid Culture Media by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Journal of Clinical Microbiology ·Aurélie Lotz, Agnès Ferroni, Jean‐Luc Béretti, Brunhilde Dauphin, Étienne Carbonnelle, Hélène Guet‐Revillet, Nicolas Véziris, Béate Heym, Vincent Jarlier, Jean‐Louis Gaillard, Catherine Pierre-Audigier, Eric Frapy, Patrick Berche, Xavier Nassif, Emmanuelle Bille	2010	123
7	Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis European Respiratory Journal ·Lorenzo Guglielmetti, Marie Jaspard, Damien Le Dû, Marie Lachâtre, Dhiba Marigot-Outtandy, Christine Bernard, Nicolas Véziris, J. Robert, Yazdan Yazdanpanah, Éric Caumes, M. Jachym	2016	103
8	Combinations of R207910 with Drugs Used To Treat Multidrug-Resistant Tuberculosis Have the Potential To Shorten Treatment Duration Antimicrobial Agents and Chemotherapy ·Nacer Lounis, Nicolas Véziris, Aurélie Chauffour, C. Truffot-Pernot, Koen Andries, Vincent Jarlier	2006	100
9	Performance of the Genotype MTBDR Line Probe Assay for Detection of Resistance to Rifampin and Isoniazid in Strains of Mycobacterium tuberculosis with Low- and High-Level Resistance Journal of Clinical Microbiology ·Florence Brossier, Nicolas Véziris, C. Truffot-Pernot, Vincent Jarlier, Wladimir Sougakoff	2006	98
10	In Vivo Evaluation of Antibiotic Activity Against Mycobacterium abscessus The Journal of Infectious Diseases ·Isabelle Lerat, Emmanuelle Cambau, Romain Roth dit Bettoni, Jean‐Louis Gaillard, Vincent Jarlier, Chantal Truffot, Nicolas Véziris	2013	86
11	Molecular Investigation of Resistance to the Antituberculous Drug Ethionamide in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis Antimicrobial Agents and Chemotherapy ·Florence Brossier, Nicolas Véziris, C. Truffot-Pernot, Vincent Jarlier, Wladimir Sougakoff	2010	71
12	Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients Journal of Cystic Fibrosis ·Anne‐Laure Roux, Émilie Catherinot, Nathalie Soismier, Béate Heym, Gil Bellis, Lydie Lemonnier, R. Chiron, Brigitte Fauroux, Muriel Le Bourgeois, À. Munck, Isabelle Pin, Isabelle Sermet‐Gaudelus, Cristina Gutierrez, Nicolas Véziris, Vincent Jarlier, Emmanuelle Cambau, Jean‐Louis Herrmann, Didier Guillemot, Jean‐Louis Gaillard	2014	69
13	Infections caused byMycobacterium abscessus: epidemiology, diagnostic tools and treatment Expert Review of Anti-infective Therapy ·Faïza Mougari, Lorenzo Guglielmetti, Laurent Raskine, Isabelle Sermet‐Gaudelus, Nicolas Véziris, Emmanuelle Cambau	2016	65
14	Extending the Definition of the GyrB Quinolone Resistance-Determining Region in Mycobacterium tuberculosis DNA Gyrase for Assessing Fluoroquinolone Resistance in M. tuberculosis Antimicrobial Agents and Chemotherapy ·Alix Pantel, S. Petrella, Nicolas Véziris, Florence Brossier, Sylvaine Bastian, Vincent Jarlier, Claudine Mayer, Alexandra Aubry	2012	63
15	Should Moxifloxacin Be Used for the Treatment of Extensively Drug-Resistant Tuberculosis? An Answer from a Murine Model Antimicrobial Agents and Chemotherapy ·Julien Poissy, Alexandra Aubry, Christine Fernandez, Marie-Catherine Lott, Aurélie Chauffour, Vincent Jarlier, Robert Farinotti, Nicolas Véziris	2010	62
16	Sterilizing Activity of R207910 (TMC207)-containing Regimens in the Murine Model of Tuberculosis American Journal of Respiratory and Critical Care Medicine ·Murad Ibrahim, C. Truffot-Pernot, Koen Andries, Vincent Jarlier, Nicolas Véziris	2009	61
17	Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis Emerging infectious diseases ·Lawrence Mbuagbaw, Lorenzo Guglielmetti, Catherine Hewison, Nyasha Bakare, Mathieu Bastard, Éric Caumes, Mathilde Fréchet-Jachym, J. Robert, Nicolas Véziris, Naira Khachatryan, Tinatin Kotrikadze, Արմեն Հայրապետյան, Zaza Avaliani, Holger J. Schünemann, Christian Lienhardt	2019	61
18	Rifabutin: where do we stand in 2016? Journal of Antimicrobial Chemotherapy ·Yoann Crabol, Émilie Catherinot, Nicolas Véziris, Vincent Jullien, Olivier Lortholary	2016	60
19	Fluoroquinolone-Containing Third-Line Regimen against Mycobacterium tuberculosis In Vivo Antimicrobial Agents and Chemotherapy ·Nicolas Véziris, C. Truffot-Pernot, Alexandra Aubry, Vincent Jarlier, Nacer Lounis	2003	60
20	Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies Antimicrobial Agents and Chemotherapy ·Faïza Mougari, Feriel Bouziane, Flora Crockett, Rachid Nessar, Françoise Chau, Nicolas Véziris, Guillaume Sapriel, Laurent Raskine, Emmanuelle Cambau	2016	54

About Nicolas Véziris

Nicolas Véziris is a scholar working on Infectious Diseases, Epidemiology, Small Animals, Molecular Medicine and Microbiology, having authored 139 papers that have together received 3.5k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (115 papers), Mycobacterium research and diagnosis (87 papers), Infectious Diseases and Tuberculosis (42 papers), Pneumocystis jirovecii pneumonia detection and treatment (18 papers), Cancer therapeutics and mechanisms (17 papers), Infectious Diseases and Mycology (17 papers), Diagnosis and treatment of tuberculosis (16 papers) and Antibiotic Resistance in Bacteria (11 papers). The work is most often cited by research in Infectious Diseases (2.7k citations), Microbiology (78 citations), Molecular Medicine (441 citations), Epidemiology (2.7k citations) and Small Animals (543 citations). Nicolas Véziris has collaborated with scholars based in France, Morocco and United States. Frequent co-authors include Vincent Jarlier, Florence Brossier, C. Truffot-Pernot, Alexandra Aubry, Wladimir Sougakoff, Emmanuelle Cambau, Nacer Lounis, Aurélie Chauffour, Koen Andries and Jean‐Louis Gaillard. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy, Emerging infectious diseases and PLoS neglected tropical diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact